Advancements in Spermatogenesis In Vitro: From Murine Success to Human Applications.

IF 3.3 3区 医学 Q2 OBSTETRICS & GYNECOLOGY
Reproductive Medicine and Biology Pub Date : 2026-03-19 eCollection Date: 2026-01-01 DOI:10.1002/rmb2.70044
Maki Kamoshita
{"title":"Advancements in Spermatogenesis In Vitro: From Murine Success to Human Applications.","authors":"Maki Kamoshita","doi":"10.1002/rmb2.70044","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Male infertility due to spermatogenic failure remains a global challenge. While in vitro spermatogenesis (IVS) offers potential for fertility preservation, recapitulating the complex, species-specific testicular niche remains a formidable task. This review evaluates IVS progress and bottlenecks across rodents, primates, domestic animals, and humans.</p><p><strong>Methods: </strong>This review summarizes a comprehensive literature synthesis of IVS methodologies, including organ culture, microfluidics, 3D organoids, and induced pluripotent stem cell (iPSC)-derived systems. Particular focus was placed on the technical evolution from the foundational gas-liquid interface method to the development of bioengineering platforms.</p><p><strong>Main findings: </strong>Murine IVS systems have successfully and consistently produced fertile offspring. Conversely, human and non-human primate models show meiotic arrest, with differentiation typically stagnating at pre-meiotic stages. Although domestic animal models have occasionally yielded haploid cells, efficiency remains low. Recent single-cell analyses suggest that disrupted somatic-germ cell communication is a key driver of these failures.</p><p><strong>Conclusion: </strong>Bridging the gap between rodent success and human application requires integrating developmental biology with precision engineering. Future efforts must focus on establishing rigorous epigenetic and functional validation to ensure the safety and efficacy of IVS for clinical reproductive medicine.</p>","PeriodicalId":21116,"journal":{"name":"Reproductive Medicine and Biology","volume":"25 1","pages":"e70044"},"PeriodicalIF":3.3000,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13045498/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive Medicine and Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/rmb2.70044","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Male infertility due to spermatogenic failure remains a global challenge. While in vitro spermatogenesis (IVS) offers potential for fertility preservation, recapitulating the complex, species-specific testicular niche remains a formidable task. This review evaluates IVS progress and bottlenecks across rodents, primates, domestic animals, and humans.

Methods: This review summarizes a comprehensive literature synthesis of IVS methodologies, including organ culture, microfluidics, 3D organoids, and induced pluripotent stem cell (iPSC)-derived systems. Particular focus was placed on the technical evolution from the foundational gas-liquid interface method to the development of bioengineering platforms.

Main findings: Murine IVS systems have successfully and consistently produced fertile offspring. Conversely, human and non-human primate models show meiotic arrest, with differentiation typically stagnating at pre-meiotic stages. Although domestic animal models have occasionally yielded haploid cells, efficiency remains low. Recent single-cell analyses suggest that disrupted somatic-germ cell communication is a key driver of these failures.

Conclusion: Bridging the gap between rodent success and human application requires integrating developmental biology with precision engineering. Future efforts must focus on establishing rigorous epigenetic and functional validation to ensure the safety and efficacy of IVS for clinical reproductive medicine.

体外精子发生的进展:从小鼠成功到人类应用。
背景:由于生精失败导致的男性不育仍然是一个全球性的挑战。虽然体外精子发生(IVS)提供了保留生育能力的潜力,但再现复杂的、物种特异性的睾丸生态位仍然是一项艰巨的任务。本文综述了啮齿动物、灵长类动物、家畜和人类IVS的进展和瓶颈。方法:本文综述了IVS方法的综合文献,包括器官培养、微流体、3D类器官和诱导多能干细胞(iPSC)衍生系统。特别关注的是从基础气液界面方法到生物工程平台发展的技术演变。主要发现:小鼠IVS系统成功且持续地产生可育后代。相反,人类和非人类灵长类动物模型显示减数分裂停滞,分化通常停滞在减数分裂前阶段。虽然国内动物模型偶尔产生单倍体细胞,但效率仍然很低。最近的单细胞分析表明,中断的体细胞-生殖细胞通信是这些失败的关键驱动因素。结论:缩小啮齿动物成功与人类应用之间的差距需要将发育生物学与精密工程相结合。未来的工作必须集中在建立严格的表观遗传学和功能验证,以确保IVS在临床生殖医学中的安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
5.90%
发文量
53
审稿时长
20 weeks
期刊介绍: Reproductive Medicine and Biology (RMB) is the official English journal of the Japan Society for Reproductive Medicine, the Japan Society of Fertilization and Implantation, the Japan Society of Andrology, and publishes original research articles that report new findings or concepts in all aspects of reproductive phenomena in all kinds of mammals. Papers in any of the following fields will be considered: andrology, endocrinology, oncology, immunology, genetics, function of gonads and genital tracts, erectile dysfunction, gametogenesis, function of accessory sex organs, fertilization, embryogenesis, embryo manipulation, pregnancy, implantation, ontogenesis, infectious disease, contraception, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书